Skip to content

i4KIDS News

Confirmed the granting of Aid for R+D+i networks to carry out programs for the valorization and transfer of research results from AGAUR.
AGAUR

Last December, AGAUR confirmed the granting of Aid for R+D+i networks to carry out programs for the valorization and transfer of research results.

This grant supports the continuity of the i4KIDS Pediatric Innovation Hub for the next 3 years.

With this call, AGAUR (University and Research Grants Management Agency) finances programs for the valorization and transfer of research results to the productive sector managed by coordinating entities of R+D+I networks.

With this aid, the aim is to promote the collaboration of the research groups of the different entities that, due to the themes of their research, have common challenges and objectives of economic and social interest and that can join R+D+i networks.

The R+D+i networks have to promote the collaboration of research groups from different institutions among themselves and with companies from interesting economic sectors, promoting interdisciplinarity and multidisciplinarity.

 

 

Related News
i4KIDS Training Capsule

Uncategorized

i4KIDS and Catalonia.Health brought together startup leaders, researchers and healthcare professionals to discuss funding, regulatory strategy and international growth. The session featured Gisela Lorente (Aptadel Therapeutics), Marc Martinell (Minoryx Therapeutics) and Stefanos Theoharis (OneChain Immunotherapeutics), highlighting Barcelona's growing role as a leading hub for paediatric health innovation.
CogniTOT

Uncategorized

The European project i4KIDS-4RARE has selected CogniTOT, a language-independent digital cognitive assessment tool developed by Liltoda Ltd, as the winning solution of its Neuroepilepsy Innovation Programme. Validated in more than 1,000 children across ten countries, the tool will now enter a pilot phase within the EpiCARE network to assess its potential for the early detection and monitoring of cognitive impairment in children living with rare epilepsies.

Uncategorized

The i4KIDS Acceleration Programme 2026 has officially launched its new cohort, bringing together five high-potential projects that showcase the diversity and strength of paediatric innovation. From breakthrough therapies for rare diseases and childhood cancer to advanced medical technologies and digital solutions tailored for paediatric care, the selected initiatives address pressing unmet clinical needs. Through a structured training and mentoring pathway, the programme will support teams in advancing clinical validation, regulatory readiness, technology transfer and market access, with a strong focus on delivering sustainable solutions and tangible impact for children and families.